Skip to content Skip to footer
Subscribe Now
EXCLUSIVE
Exclusive Interview with PharmaShots: Moshe Safran of RSIP Vision Share Insight on the 3D Reconstruction Technology
In an interview with PharmaShots, Moshe Safran, CEO at RSIP Vision shared his views on the new coronary module in the complete 3D reconstruction of the coronary vasculature during angiographyShots:The company reported the 3D reconstruction technology that focused on AI to generate 3D models of patient anatomy from 2D images. The purpose of the technology is to create precise,…
February 7, 20220Comments
Viewpoints_Laura Dix
VIEWPOINTS
PharmaShots Interview: Accenture Life Sciences’ Laura Dix Shares Insights on the New Rules of Engagement to Provide HCPs New Interactions
In an interview with PharmaShots, Laura Dix, a Managing Director in Accenture’s Life Sciences Strategy and Consulting practice shares her views on the new research & provides more useful, data-driven information to HCPs Shots:The company unveiled new research, titled The “New” Rules of Engagement & which have increased their relevance during COVID-19 through more valuable and meaningful interactions with…
February 2, 20220Comments
Viewpoints_Laurent Levy
VIEWPOINTS
PharmaShots Interview: Nanobiotix’s Laurent Levy Shares Insights on the P-III (NANORAY-312) Study of NBTXR3 for the Treatment of Head and Neck Squamous Cell Carcinoma
In an interview with PharmaShots, Laurent Levy, Co-Founder & CEO at Nanobiotix shares his views on the first patient enrollment of NBTXR3 in P-III (NANORAY-312) study for the treatment of head and neck squamous cell carcinomaShots:The first patient has been enrolled in P-III (NANORAY-312) study to evaluate the efficacy & safety of NBTXR3 with/out cetuximab vs radiotherapy with/out cetuximab…
January 31, 20220Comments
Spotlight Interview_Michael Sassano
SPOTLIGHT
Spotlight Interview with Michael Sassano, CEO and Chairman of the Board for Somai Pharmaceuticals
On February 01, 2022, PharmaShots will present the second interview in its new interview section, “Spotlight- Company of the Month’’.Company of the month is our new exclusive feature under which we are interviewing the key leaders of the start-ups that are providing fierce solutions. We pick one company every month and interview them about…
January 27, 20220Comments
Viewpoints_Ilse Eder
VIEWPOINTS
PharmaShots Interview: E&E CRO Consulting’s Ilse Eder Shares Insights on the Trends of Clinical Research & New Healthcare Technologies
In an interview with PharmaShots, Ilse Eder, CEO at E&E CRO Consulting shares her views on the breakthrough healthcare technologies to improve patient outcomesShots:Principal Technologies is an investor in the MedTech space. Its first investment is an 80% stake in E&E which is focused on helping companies earn international distribution permits via clinical studies Principal Technologies focuses on identifying…
January 25, 20220Comments